1. Understand the molecular heterogeneity of Medulloblastoma
2. Develop therapies specific to the molecular subgroup
3. Identify patients that can be cured with less intensive therapy

Session date: 
10/05/2017 - 12:00pm to 1:00pm CDT
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Amar Gajjar, MD